Use of bevacizumab to facilitate up-front chemoradiation in poor-risk patients with glioblastoma multiforme by improving neurologic function

2059 Background: Poor postoperative neurologic function due to mass effect and steroid-refractory perilesional edema often limits the ability of patients with glioblastoma multiforme (GBM) to toler...